These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9571143)

  • 21. Mechanism of action of a new component of the Ca(2+)-dependent proteolytic system in rat brain: the calpain activator.
    Melloni E; Michetti M; Salamino F; Sparatore B; Pontremoli S
    Biochem Biophys Res Commun; 1998 Aug; 249(3):583-8. PubMed ID: 9731179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CAPN 8: isolation of a new mouse calpain-isoenzyme.
    Braun C; Engel M; Theisinger B; Welter C; Seifert M
    Biochem Biophys Res Commun; 1999 Jul; 260(3):671-5. PubMed ID: 10403824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of genetic insights into calpain biology.
    Sorimachi H; Hata S; Ono Y
    J Biochem; 2011 Jul; 150(1):23-37. PubMed ID: 21610046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanding members and roles of the calpain superfamily and their genetically modified animals.
    Sorimachi H; Hata S; Ono Y
    Exp Anim; 2010; 59(5):549-66. PubMed ID: 21030783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Domain II of m-calpain is a Ca(2+)-dependent cysteine protease.
    Hata S; Sorimachi H; Nakagawa K; Maeda T; Abe K; Suzuki K
    FEBS Lett; 2001 Jul; 501(2-3):111-4. PubMed ID: 11470267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calpain: new perspectives in molecular diversity and physiological-pathological involvement.
    Saido TC; Sorimachi H; Suzuki K
    FASEB J; 1994 Aug; 8(11):814-22. PubMed ID: 8070630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The calpain-system of Drosophila melanogaster: coming of age.
    Friedrich P; Tompa P; Farkas A
    Bioessays; 2004 Oct; 26(10):1088-96. PubMed ID: 15382138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human mu-calpain by conformationally constrained calpastatin peptides.
    Pfizer J; Assfalg-Machleidt I; Machleidt W; Schaschke N
    Biol Chem; 2008 Jan; 389(1):83-90. PubMed ID: 18095873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between catalytically inactive calpain and calpastatin. Evidence for its occurrence in stimulated cells.
    Averna M; Stifanese R; De Tullio R; Defranchi E; Salamino F; Melloni E; Pontremoli S
    FEBS J; 2006 Apr; 273(8):1660-8. PubMed ID: 16623703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
    Cuerrier D; Moldoveanu T; Inoue J; Davies PL; Campbell RL
    Biochemistry; 2006 Jun; 45(24):7446-52. PubMed ID: 16768440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis.
    Wang KK; Posmantur R; Nadimpalli R; Nath R; Mohan P; Nixon RA; Talanian RV; Keegan M; Herzog L; Allen H
    Arch Biochem Biophys; 1998 Aug; 356(2):187-96. PubMed ID: 9705209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calpains: an elaborate proteolytic system.
    Ono Y; Sorimachi H
    Biochim Biophys Acta; 2012 Jan; 1824(1):224-36. PubMed ID: 21864727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis-linked gene product ALG-2 is a new member of the calpain small subunit subfamily of Ca2+-binding proteins.
    Lo KW; Zhang Q; Li M; Zhang M
    Biochemistry; 1999 Jun; 38(23):7498-508. PubMed ID: 10360947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The beta- and gamma-CH2 of B27-WT's Leu11 and Ile18 side chains play a direct role in calpain inhibition.
    Betts R; Anagli J
    Biochemistry; 2004 Mar; 43(9):2596-604. PubMed ID: 14992597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Calcium activated neutral protease and its endogenous inhibitor].
    Zhang ML
    Sheng Li Ke Xue Jin Zhan; 1998 Jul; 29(3):267-70. PubMed ID: 12501651
    [No Abstract]   [Full Text] [Related]  

  • 36. Structural characterization of a highly stable cysteine protease ervatamin C.
    Kundu S; Sundd M; Jagannadham MV
    Biochem Biophys Res Commun; 1999 Nov; 264(3):635-42. PubMed ID: 10543984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N-terminal domain of human centrin 2 has a closed structure, binds calcium with a very low affinity, and plays a role in the protein self-assembly.
    Yang A; Miron S; Duchambon P; Assairi L; Blouquit Y; Craescu CT
    Biochemistry; 2006 Jan; 45(3):880-9. PubMed ID: 16411764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folding transitions in calpain activator peptides studied by solution NMR spectroscopy.
    Toke O; Bánóczi Z; Tárkányi G; Friedrich P; Hudecz F
    J Pept Sci; 2009 Jun; 15(6):404-10. PubMed ID: 19378261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis.
    Galvez AS; Diwan A; Odley AM; Hahn HS; Osinska H; Melendez JG; Robbins J; Lynch RA; Marreez Y; Dorn GW
    Circ Res; 2007 Apr; 100(7):1071-8. PubMed ID: 17332428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystallization and structural details of Ca(2+)-induced conformational changes in the EF-hand domain VI of calpain.
    Cygler M; Grochulski P; Blanchard H
    Methods Mol Biol; 2002; 172():243-60. PubMed ID: 11833352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.